Ryan Whitaker, MD, PhD

Assistant Professor

Dr. Whitaker is an Assistant Professor in the Department of Radiation Oncology at Vanderbilt-Ingram Cancer Center, where he focuses on the treatment of thoracic and head and neck malignancies. His primary research interest is in the biological interplay between radiotherapy and immunotherapy to develop novel strategies for the treatment of lung cancer and other cancers. From 2020 - 2021, Dr. Whitaker served as the ASTRO-AstraZeneca Industry Fellow where he worked as a member of a team focused on the development and implementation of AstraZeneca's immunotherapy agents in non-small cell and small cell lung cancer. 


  • ASTRO-AstraZeneca Industry Fellow, 2020-2021
  • Chief Resident, Radiation Oncology, Vanderbilt University Medical Center, 2021-2022

Education and Training

  • Residency, Vanderbilt University Medical Center, Nashville, TN, 2022
  • Internship, Scripps Mercy Hospital, San Diego, CA, 2018
  • M.D., Medical University of South Carolina, Charleston, SC, 2017
  • Ph.D., Drug Discovery and Biomedical Sciences, Medical University of South Carolina, 2017
  • B.S., Chemical Engineering, University of Iowa, 2008